Owing to the role of neonatal Fc receptor (FcRn) in autoantibody production, FcRn could be a promising therapeutic target for treating IgG-mediated autoimmune disorders by preventing the persistent autoantigen presentation and consequently inhibiting long-term autoantibody production (79, 80). The gene discussed is FCGRT; the disease is Autoimmunity.